CHARLOTTE, N.C., Nov. 2 /PRNewswire/ — Dramatic progress in the
detection of horrendous genetic diseases in days-old human embryos is
opening new frontiers in reproductive medicine, Charlotte doctors say,
raising the possibility that fertility physicians may one day be sought
almost as much for their genetic expertise as for enabling pregnancies.
Rapid progress in avoiding catastrophic inherited diseases — boosted
by research in genetic development that won the Nobel Prize for a North
Carolina scientist last month — is unfolding from a procedure called
pre-implantation genetic diagnosis (PGD). Used in conjunction with in vitro
fertilization (IVF), PGD allows specialists to biopsy embryos in their
first three, five, and six days of existence for indicators of inherited
diseases and then select only healthy ones for implantation.